Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 17INDUSTRY 12NETWORK 2UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Stomach Neoplasms 1Small Cell Lung Carcinoma 1Neoplasm Metastasis 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colonic Neoplasms 1

Interventions

Cisplatin 2nedaplatin 1durvalumab 1camrelizumab 1apatinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Paclitaxel 1Irinotecan 1Drug Therapy 1Capecitabine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Esophageal Squamous Cell Carcinoma × Irinotecan × Clear all
NCT03603756 2020-02-11

SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer

ChineseAMS

Phase 2 Unknown
45 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡